Found: 164
Select item for more details and to access through your institution.
Correction: Patient eligibility for trials with imaging response assessment at the time of molecular tumor board presentation.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Sequential therapy of refractory metastatic pancreatic cancer with 5-FU/LV/irinotecan (FOLFIRI) vs. 5-FU/LV/oxaliplatin (OFF). The PANTHEON trial (AIO PAK 0116).
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2024, v. 150, n. 7, p. 1, doi. 10.1007/s00432-024-05827-x
- By:
- Publication type:
- Article
Toxicity-Induced Discontinuation of Immune Checkpoint Inhibitors in Metastatic Urothelial Cancer: 6-Year Experience from a Specialized Uro-Oncology Center.
- Published in:
- Cancers, 2024, v. 16, n. 12, p. 2246, doi. 10.3390/cancers16122246
- By:
- Publication type:
- Article
Patient eligibility for trials with imaging response assessment at the time of molecular tumor board presentation.
- Published in:
- Cancer Imaging, 2024, v. 24, p. 1, doi. 10.1186/s40644-024-00708-5
- By:
- Publication type:
- Article
Adjuvant Treatment with S-1 in Patients after R0-Resection of Adenocarcinoma of the Stomach and Esophagogastric Junction: A Multicenter Phase I/II Feasibility Study (GMBH-STO-0114).
- Published in:
- Oncology Research & Treatment, 2024, v. 47, n. 6, p. 251, doi. 10.1159/000538143
- By:
- Publication type:
- Article
Three-month life expectancy as inclusion criterion for clinical trials in advanced pancreatic cancer: is it really a valid tool for patient selection?
- Published in:
- Clinical & Translational Oncology, 2024, v. 26, n. 5, p. 1268, doi. 10.1007/s12094-023-03323-1
- By:
- Publication type:
- Article
Prognostic and predictive impact of metastatic organ involvement on maintenance therapy in advanced metastatic colorectal cancer: Subgroup analysis of patients treated within the PanaMa trial (AIO KRK 0212).
- Published in:
- International Journal of Cancer, 2024, v. 154, n. 5, p. 863, doi. 10.1002/ijc.34760
- By:
- Publication type:
- Article
Supporting the decision to perform molecular profiling for cancer patients based on routinely collected data through the use of machine learning.
- Published in:
- Clinical & Experimental Medicine, 2024, v. 24, n. 1, p. 1, doi. 10.1007/s10238-024-01336-w
- By:
- Publication type:
- Article
Early mortality in German patients with lung cancer: risk factors associated with 30-and 60-day mortality.
- Published in:
- Clinical & Experimental Medicine, 2023, v. 23, n. 8, p. 5183, doi. 10.1007/s10238-023-01187-x
- By:
- Publication type:
- Article
Implementing precision oncology for sarcoma patients: the CCC<sup>LMU</sup>molecular tumor board experience.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 15, p. 13973, doi. 10.1007/s00432-023-05179-y
- By:
- Publication type:
- Article
A rare case of locally advanced DNA mismatch‐repair‐deficient adenocarcinoma of the colon in a 16‐year‐old male treated with neoadjuvant immunotherapy and single‐incision laparoscopic resection.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, n. 11, p. 1, doi. 10.1002/pbc.30653
- By:
- Publication type:
- Article
The Oncology Biomarker Discovery framework reveals cetuximab and bevacizumab response patterns in metastatic colorectal cancer.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-41011-4
- By:
- Publication type:
- Article
Key Prognostic Factors Create a Composite Risk Score to Stratify Patients into High- and Low-Treatment Benefit Groups: A Multicenter, Retrospective Data Analysis of 84 Metastatic Colorectal Cancer Patients Treated with Regorafenib as Part of the CORRECT and CONSIGN Trials
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 9, p. 348, doi. 10.1159/000531268
- By:
- Publication type:
- Article
Relevance of tumor boards for the inclusion of patients in oncological clinical trials.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 10, p. 7601, doi. 10.1007/s00432-022-04559-0
- By:
- Publication type:
- Article
TPX2 expression as a negative predictor of gemcitabine efficacy in pancreatic cancer.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 1, p. 175, doi. 10.1038/s41416-023-02295-x
- By:
- Publication type:
- Article
Stressors related to the COVID-19 pandemic and their association with distress, depressive, and anxiety symptoms in cancer out-patients.
- Published in:
- Frontiers in Psychology, 2023, p. 1, doi. 10.3389/fpsyg.2023.1100236
- By:
- Publication type:
- Article
Integrated Analysis of the RASH Study with the Use of the "Burden of Therapy" (BOTh ®TM) Methodology—A Novel Tool for Assessing Adverse Events in Metastatic Pancreatic Cancer.
- Published in:
- Current Oncology, 2023, v. 30, n. 6, p. 5828, doi. 10.3390/curroncol30060436
- By:
- Publication type:
- Article
Serum biomarker panel diagnostics in pancreatic ductal adenocarcinoma: the clinical utility of soluble interleukins, IFN-γ, TNF-α and PD-1/PD-L1 in comparison to established serum tumor markers.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 6, p. 2463, doi. 10.1007/s00432-022-04112-z
- By:
- Publication type:
- Article
Swapping data: A pragmatic approach for enabling academic-industrial partnerships.
- Published in:
- Digital Health, 2023, p. 1, doi. 10.1177/20552076231172120
- By:
- Publication type:
- Article
Clinical Impact of Structured Post-Operative Surveillance in Resected Pancreatic Adenocarcinoma: Results from a Retrospective Cohort Study.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 3, p. 106, doi. 10.1159/000528722
- By:
- Publication type:
- Article
Standard diametric versus volumetric early tumor shrinkage as a predictor of survival in metastatic colorectal cancer: subgroup findings of the randomized, open-label phase III trial FIRE-3 / AIO KRK-0306.
- Published in:
- European Radiology, 2023, v. 33, n. 2, p. 1174, doi. 10.1007/s00330-022-09053-2
- By:
- Publication type:
- Article
Proteomics uncover EPHA2 as a potential novel therapeutic target in colorectal cancer cell lines with acquired cetuximab resistance.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 2, p. 669, doi. 10.1007/s00432-022-04416-0
- By:
- Publication type:
- Article
Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 2, p. 913, doi. 10.1007/s00432-022-04407-1
- By:
- Publication type:
- Article
Swapping data: A pragmatic approach for enabling academic-industrial partnerships.
- Published in:
- Digital Health, 2023, v. 9, p. 1, doi. 10.1177/20552076231172120
- By:
- Publication type:
- Article
EMT-Related Genes Have No Prognostic Relevance in Metastatic Colorectal Cancer as Opposed to Stage II/III: Analysis of the Randomised, Phase III Trial FIRE-3 (AIO KRK 0306; FIRE-3).
- Published in:
- Cancers, 2022, v. 14, n. 22, p. 5596, doi. 10.3390/cancers14225596
- By:
- Publication type:
- Article
Strategies to successfully prevent COVID-19 outbreak in vulnerable uro-oncology patient population.
- Published in:
- Infection, 2022, v. 50, n. 5, p. 1131, doi. 10.1007/s15010-022-01775-1
- By:
- Publication type:
- Article
The impact of adjuvant therapy on outcome in UICC stage I pancreatic cancer.
- Published in:
- International Journal of Cancer, 2022, v. 151, n. 6, p. 914, doi. 10.1002/ijc.34044
- By:
- Publication type:
- Article
Germline Polymorphisms in Genes Involved in the Antioxidant System Predict the Efficacy of Cetuximab in Metastatic Colorectal Cancer Patients Enrolled in FIRE-3 Trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Preanalytical Variables in the Analysis of Mitochondrial DNA in Whole Blood and Plasma from Pancreatic Cancer Patients.
- Published in:
- Diagnostics (2075-4418), 2022, v. 12, n. 8, p. 1905, doi. 10.3390/diagnostics12081905
- By:
- Publication type:
- Article
PD-L1 Amino Acid Position 88 Represents a Hotspot for PD-L1 Stability With Relevance for PD-L1 Inhibition.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.941666
- By:
- Publication type:
- Article
Assessment of Metastatic Colorectal Cancer Patients' Preferences for Biologic Treatments in Germany Using a Discrete Choice Experiment.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Bacterial Lipopolysaccharide as a Negative Predictor of Adjuvant Gemcitabine Efficacy in Pancreatic Cancer.
- Published in:
- JNCI Cancer Spectrum, 2022, v. 6, n. 3, p. 1, doi. 10.1093/jncics/pkac039
- By:
- Publication type:
- Article
Should routine risk reduction procedures for the prevention and control of pandemics become a standard in all oncological outpatient clinics? The prospective COVID-19 cohort study: protect-CoV.
- Published in:
- Medical Oncology, 2022, v. 39, n. 6, p. 1, doi. 10.1007/s12032-022-01700-4
- By:
- Publication type:
- Article
Liquid Biopsy in Colorectal Cancer: Quo Vadis? Implementation of Liquid Biopsies in Routine Clinical Patient Care in Two German Comprehensive Cancer Centers.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.870411
- By:
- Publication type:
- Article
Distress in hospitalized cancer patients: Associations with personality traits, clinical and psychosocial characteristics.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Survival after secondary liver resection in metastatic colorectal cancer: Comparing data of three prospective randomized European trials (LICC, CELIM, FIRE‐3).
- Published in:
- International Journal of Cancer, 2022, v. 150, n. 8, p. 1341, doi. 10.1002/ijc.33881
- By:
- Publication type:
- Article
FIRE-9 - PORT / AIO-KRK-0418: a prospective, randomized, open, multicenter Phase III trial to investigate the efficacy of adjuvant/additive chemotherapy in patients with definitely-treated metastatic colorectal cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Response and Disease Dynamics in Untreated Metastatic Colorectal Cancer With Bevacizumab-Based Sequential vs. Combination Chemotherapy—Analysis of the Phase 3 XELAVIRI Trial.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.751453
- By:
- Publication type:
- Article
Mutational profiles of metastatic colorectal cancer treated with FOLFIRI plus cetuximab or bevacizumab before and after secondary resection (AIO KRK 0306; FIRE‐3).
- Published in:
- International Journal of Cancer, 2021, v. 149, n. 11, p. 1935, doi. 10.1002/ijc.33747
- By:
- Publication type:
- Article
Prognostic and Predictive Impact of Primary Tumor Sidedness for Previously Untreated Advanced Colorectal Cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Quantitative Imaging Biomarkers of the Whole Liver Tumor Burden Improve Survival Prediction in Metastatic Pancreatic Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 22, p. 5732, doi. 10.3390/cancers13225732
- By:
- Publication type:
- Article
BRAF V600E Mutation in First-Line Metastatic Colorectal Cancer: An Analysis of Individual Patient Data From the ARCAD Database.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Correction: Bacterial lipopolysaccharide as negative predictor of gemcitabine efficacy in advanced pancreatic cancer - translational results from the AIO-PK0104 Phase 3 study.
- Published in:
- 2021
- By:
- Publication type:
- corrected article
Secondary resistance to anti-EGFR therapy by transcriptional reprogramming in patient-derived colorectal cancer models.
- Published in:
- Genome Medicine, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13073-021-00926-7
- By:
- Publication type:
- Article
Random survival forests identify pathways with polymorphisms predictive of survival in KRAS mutant and KRAS wild-type metastatic colorectal cancer patients.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-91330-z
- By:
- Publication type:
- Article
NGS-guided precision oncology in metastatic breast and gynecological cancer: first experiences at the CCC Munich LMU.
- Published in:
- Archives of Gynecology & Obstetrics, 2021, v. 303, n. 5, p. 1331, doi. 10.1007/s00404-020-05881-z
- By:
- Publication type:
- Article
Patients with colorectal cancer and brain metastasis: The relevance of extracranial metastatic patterns predicting time intervals to first occurrence of intracranial metastasis and survival.
- Published in:
- International Journal of Cancer, 2021, v. 148, n. 8, p. 1919, doi. 10.1002/ijc.33364
- By:
- Publication type:
- Article
Implementation of Precision Oncology for Patients with Metastatic Breast Cancer in an Interdisciplinary MTB Setting.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 4, p. 733, doi. 10.3390/diagnostics11040733
- By:
- Publication type:
- Article
Information, communication, and cancer patients' trust in the physician: what challenges do we have to face in an era of precision cancer medicine?
- Published in:
- Supportive Care in Cancer, 2021, v. 29, n. 4, p. 2171, doi. 10.1007/s00520-020-05692-7
- By:
- Publication type:
- Article
Nintedanib plus mFOLFOX6 as second‐line treatment of metastatic, chemorefractory colorectal cancer: The randomised, placebo‐controlled, phase II TRICC‐C study (AIO‐KRK‐0111).
- Published in:
- International Journal of Cancer, 2021, v. 148, n. 6, p. 1428, doi. 10.1002/ijc.33296
- By:
- Publication type:
- Article